The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Neuromodulation Market Evolve From 2026 To 2030?
The neuromodulation market has seen swift expansion in recent years. Its valuation is forecast to climb from $7.62 billion in 2025 to $8.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. The prior period’s growth was driven by factors such as the increasing prevalence of chronic pain conditions, a rising incidence of neurological disorders, wider acceptance of minimally invasive therapies, the expansion of specialized pain management centers, and the availability of advanced implantable devices.
The neuromodulation market is anticipated to experience significant expansion over the coming years. By 2030, its valuation is projected to reach $12.88 billion, demonstrating a compound annual growth rate (CAGR) of 11.1%. This projected growth during the forecast timeframe is primarily driven by several factors, including the increasing integration of AI-assisted neuromodulation systems, a heightened demand for home-based neuromodulation treatments, a broader range of indications for psychiatric and neurological conditions, an increasing emphasis on stimulation protocols tailored to individual patients, and ongoing technological progress in biomaterials and the miniaturization of devices. Key trends anticipated during this period involve a greater uptake of implantable neuromodulation devices, increased utilization of non-invasive neuromodulation therapies, the expanding incorporation of intelligent and programmable stimulators, the broadening of neuromodulation applications beyond just pain management, and a stronger emphasis on individualized neurotherapy.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp
What Key Drivers Are Influencing The Growth Of The Neuromodulation Market?
Increasing spending on healthcare is anticipated to drive the expansion of the neuromodulation market in the future. Healthcare expenditure encompasses the overall financial outlay for health-related endeavors, covering health service delivery, both private and public health insurance, health research, and public health initiatives. This rise in spending fosters the creation and uptake of novel treatments and diagnostic tools for neurological conditions. Furthermore, enhanced financial backing enables greater exploration into emerging neuromodulation technologies, thereby boosting their effectiveness, security, and precision. For example, data from the UK’s Office for National Statistics indicated in May 2024 that overall healthcare expenditure rose by a nominal 5.6% increase in 2023, representing a 0.9% growth compared to 2022. Consequently, the increasing healthcare expenditure is propelling the expansion of the neuromodulation market.
Which Segment Areas Are Covered In The Neuromodulation Market Analysis?
The neuromodulation market covered in this report is segmented –
1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)
What Key Developments And Trends Are Impacting The Neuromodulation Market?
Leading companies in the neuromodulation market are prioritizing the development of next-generation devices, such as sophisticated implantable pulse generators (IPGs), to enhance therapeutic accuracy, improve patient comfort, and maintain their competitive standing. An IPG is a small, battery-powered device implanted beneath the skin, usually in the chest or abdomen, that provides targeted electrical stimulation to help manage neurological disorders. These innovations aim to offer increased customization, better battery performance, and simplified implantation processes. For example, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, received FDA approval for its Vercise Neural Navigator 5 software featuring STIMVIEW XT technology, intended for use with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. This platform includes both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), providing the most extensive range of therapy options to personalize DBS treatment for individuals affected by Parkinson’s disease or essential tremor.
Which Global Companies Are Actively Competing In The Neuromodulation Market?
Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation
Read the full neuromodulation market report here:
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Neuromodulation Market?
North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Neuromodulation Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp
Browse Through More Reports Similar to the Global Neuromodulation Market 2026, By The Business Research Company
Nephrologists Market Report 2020 2030 Covid 19 Implications And Growth 2026
Neurology Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Brain Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model